25th Nov 2020 12:25
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 24 November 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
3,032,818 | 2.35% | 610,041 | 0.47% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
284,635 | 0.22% | 739,005 | 0.57% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
3,317,453 | 2.57% | 1,349,046 | 1.05% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 2 | 203.8000 USD |
Purchase | 20 | 210.9800 USD |
Purchase | 30 | 211.2266 USD |
Purchase | 92 | 210.0600 USD |
Purchase | 93 | 210.7100 USD |
Purchase | 93 | 209.6675 USD |
Purchase | 100 | 211.0200 USD |
Purchase | 100 | 209.9400 USD |
Purchase | 100 | 209.6500 USD |
Purchase | 122 | 210.3644 USD |
Purchase | 125 | 209.9068 USD |
Purchase | 150 | 210.9146 USD |
Purchase | 153 | 209.6904 USD |
Purchase | 160 | 210.9000 USD |
Purchase | 204 | 210.0987 USD |
Purchase | 235 | 210.9987 USD |
Purchase | 261 | 210.7352 USD |
Purchase | 297 | 209.2742 USD |
Purchase | 320 | 209.8600 USD |
Purchase | 343 | 208.9991 USD |
Purchase | 796 | 207.6705 USD |
Purchase | 1,035 | 210.2857 USD |
Purchase | 1,800 | 208.2892 USD |
Purchase | 4,675 | 206.9012 USD |
Purchase | 5,228 | 209.9184 USD |
Purchase | 5,818 | 209.0095 USD |
Purchase | 5,911 | 209.0000 USD |
Purchase | 6,174 | 209.9214 USD |
Purchase | 6,490 | 209.9586 USD |
Purchase | 9,802 | 208.8417 USD |
Purchase | 9,931 | 209.8567 USD |
Sale | 2 | 203.8000 USD |
Sale | 7 | 205.5100 USD |
Sale | 23 | 211.2500 USD |
Sale | 200 | 206.7600 USD |
Sale | 288 | 210.3508 USD |
Sale | 292 | 210.2218 USD |
Sale | 300 | 210.2934 USD |
Sale | 300 | 207.4716 USD |
Sale | 323 | 210.0575 USD |
Sale | 400 | 208.7400 USD |
Sale | 400 | 209.9275 USD |
Sale | 420 | 209.8790 USD |
Sale | 511 | 209.2413 USD |
Sale | 533 | 210.1490 USD |
Sale | 571 | 207.4000 USD |
Sale | 644 | 210.1339 USD |
Sale | 697 | 207.5128 USD |
Sale | 700 | 209.8614 USD |
Sale | 723 | 209.7983 USD |
Sale | 791 | 210.4878 USD |
Sale | 809 | 209.8627 USD |
Sale | 1,311 | 206.5046 USD |
Sale | 1,711 | 206.6255 USD |
Sale | 1,893 | 206.9244 USD |
Sale | 2,245 | 209.0000 USD |
Sale | 3,216 | 208.8708 USD |
Sale | 3,988 | 209.1190 USD |
Sale | 4,627 | 206.8794 USD |
Sale | 5,010 | 209.9779 USD |
Sale | 6,222 | 209.0878 USD |
Sale | 6,766 | 208.8828 USD |
Sale | 8,440 | 209.8350 USD |
Sale | 10,060 | 210.1242 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 25 Nov 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected |
|
| If a connected EFM, state nature of connection |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20201125005600/en/
Copyright Business Wire 2020
Related Shares:
Barclays